Text

Objectives and questions: Total femur replacements (TFR) involve the replacement of the whole femoral bone, reconstruction of the hip and knee joints, and soft tissue reconstruction for function and joint stability. The aim of this multicentric European Musculo-Skeletal Oncology Society (EMSOS) study is to report on the functional outcome, quality of life, as well as gait analysis in patients with TFR.

Material and methods: Retrospective data from 12 international participating centres was collected. 65 patients (median (IQR) age at surgery 40 (18–56) years, 60% male) who received a TFR due to oncologic or non-oncologic indications between 01.01.1990 and 31.03.2024 were included. Patient related outcome measures (PROMs), range of motion (ROM) of the hip and knee, and gait videos were collected.

Results: At a median (IQR) follow-up of 28 months (14–126), the median (IQR) percentage MSTS score was 63% (43-73), SF-12 70% (55–79), HHS 63% (52–77), and OKS 63% (52–79); the median (IQR) extension-to-flexion ROM were 80° (70-97.5, hip) and 70° (40–90, knee). Gait videos were available for 24/65 patients (37%). The median (IQR) total Edinburgh visual gait score of the operated side was 8.5 (6–13), with deviations from norm in all patients (24/24). Compensational gait pathology on the contralateral side was detected in 23/24 patients (96%). Better outcome measures significantly correlated with younger age (all PROMs), oncologic indications (MSTS and OKS), and primary TFR implantations (MSTS).

Discussion and conclusions: Moderate to good PROM scores are to be expected after TFR, with better outcome in younger patients, undergoing primary implantations, for oncologic indications. The recurrent gait deviations observed and the compensational gait pathology on the contralateral side should be considered in TFR aftercare, remobilisation and patient counselling.